Association between intrauterine growth restriction and patent ductus arteriosus: Use of a dichorionic twin pregnancy

Chung-Yuan Yang1, Michael Fw Hoong2, Chung-Sing Li3

  • 1Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Tao-Yuan, Taiwan.

Insights

Intrauterine growth restriction (IUGR) in dichorionic twins significantly increases the risk of developing patent ductus arteriosus (PDA) and hemodynamically significant PDA (Hs-PDA). This finding highlights the importance of monitoring growth-restricted fetuses for cardiac complications.

Area of Science:

  • Neonatal Medicine
  • Perinatology
  • Fetal Cardiology

Background:

  • Selective intrauterine growth restriction (sIUGR) in dichorionic (DC) twins presents unique challenges in fetal development.
  • Patent ductus arteriosus (PDA) is a common neonatal complication, and its hemodynamically significant form (Hs-PDA) can lead to severe morbidity.

Purpose of the Study:

  • To investigate the association between sIUGR in dichorionic twins and the incidence of PDA and Hs-PDA.
  • To identify risk factors and outcomes related to PDA in this specific twin population.

Main Methods:

  • Observational cohort study and retrospective case assessment of DC twins born between 2013-2018.
  • sIUGR defined by >25% birth weight discordance and smaller twin <10th percentile.
  • PDA and Hs-PDA diagnosed via echocardiography postnatally.

Main Results:

  • Among 53 DC twins with sIUGR, PDA occurred in 28.30% and Hs-PDA in 24.53%, significantly higher than in appropriate for gestational age co-twins (7.55% and 5.66%, respectively).
  • Twins with PDA experienced higher rates of preterm birth and lower gestational age at delivery.
  • Small gestational age at delivery was a significant predictor for both PDA and Hs-PDA.

Conclusions:

  • Selective IUGR in dichorionic twins is associated with an increased risk of developing PDA and Hs-PDA.
  • Early identification and monitoring of sIUGR fetuses are crucial for managing potential cardiac complications.
Abstract